据联合国网站消息，当地时间2月5日，世界卫生组织总干事谭德塞在日内瓦举行的例行发布会上表示，目前，全球新冠疫苗接种数量已经超过了报告的感染病例总数，这既是一个令人鼓舞的好消息，但同时也再次突显出疫苗公平分配的重要性。
据此前报道，来自英国牛津大学等研究机构的最新统计数据显示，随着多国陆续大规模开展新冠疫苗接种，全球累计新冠疫苗接种剂数3日已超过累计新冠确诊病例数。
The World Health Organization (WHO) on Friday called on COVID-19 vaccine manufacturers to scale up production significantly and urged countries to share vaccine doses once they finish vaccinating their priority populations.Reiterating the negative impact of inequitable access to COVID-19 vaccines worldwide at a press briefing, WHO Director-General Dr. Tedros Adhanom Ghebreyesus said that globally the number of vaccinations has overtaken the number of reported infections, which he described as "a good news and a remarkable achievement in such a short timeframe."谭德塞表示，超过75%的新冠疫苗接种都集中在10个国家，这10个国家的国内生产总值占到全球的60%。但同时，仍有近130个国家的25亿人尚未获得任何一剂疫苗。谭德塞再次呼吁各国政府，在完成对本国医务人员和老年群体的接种工作后，分享多余的疫苗——“这是保护本国人民的最佳手段，因为高风险群体接种疫苗所花的时间越长，病毒发生变异而使疫苗失效的风险就越大。”"But more than three-quarters of those vaccination are in just 10 countries that account for almost 60 percent of global gross domestic product (GDP)," while "almost 130 countries, with 2.5 billion people, have yet to receive a single dose," he said."All governments have an obligation to protect their own people," Tedros said. "But once countries with vaccines have vaccinated their own health workers and older people, the best way to protect the rest of their own population is to share vaccines so other countries can do the same.""The longer it takes to vaccinate those most at risk everywhere, the more opportunity we give to the virus to mutate and evade vaccines," he warned. "Unless we suppress the virus everywhere, we could end up back at square one."谭德塞同时呼吁相关企业通过世卫组织提供的“新冠病毒技术获取池”( C-TAP)，分享信息、知识产权和数据，开放生产许可，允许其他医药用品制造商生产疫苗，以便扩大全球、尤其是亚非拉地区的产能。The WHO chief also urged vaccine manufacturers to ramp up production, calling on them to issue non-exclusive licenses to allow other producers to manufacture their vaccines, just as they did in the past to expand access to treatments for HIV and hepatitis C.此外，世卫组织助理总干事玛丽安热拉·西芒在发布会上表示，目前世卫组织对13种新冠疫苗展开评估，其中四种疫苗的评估进程处于非常后期的阶段——这包括中国国药集团和科兴公司的两种新冠疫苗。世卫组织目前已派团队前往中国考察相关设施。Four kinds of COVID-19 vaccines, including the Chinese Sinopharm and Sinovac Biotech vaccines, are in their very last stage of assessment, said Mariangela Simao, the World Health Organization (WHO) assistant director-general for access to medicines, vaccines and pharmaceuticals, on Friday. Simao added that the WHO has sent experts to China to assess relevant equipment.